Promotional Features

Content provided BY PerkinElmer

The Fast & The Flexible: How to Take Control of Your Clinical Data

Challenges abound with typical clinical data review. Here’s how to avoid them so that you can maintain control throughout the process.

Content provided BY PerkinElmer

Ensuring Clinicians Obtain the Right Data at the Right Time

Trials can often experience impediments great and small. Here’s how unified analytics platforms can provide real-time data for more accurate, expedient review.

Content provided BY Signant Health

Scaling up eConsent

The informed consent process is fundamental to every clinical trial. Study participants must be provided with sufficient information to understand the study, its procedures and commitments, the possible treatments they may receive, and any possible risks...

Content provided BY Yourway

How Advanced Technologies Ensure Accuracy of Your Clinical Trials

Decentralized/Virtual Clinical trials are being transformed by swiftly emerging technologies. Direct-to-patient models require trial data to be protected and accurate. Not all organizations are equipped to do that. Yourway is.

Content provided BY FedEx

Building resilient healthcare supply chains post-pandemic

COVID-19 drastically reconfigured APAC healthcare supply chains in the past year. So what’s next?

Content provided BY PharmaNutra Spa

Chronic COVID syndrome: a new study shows the positive effects of using Apportal, a targeted nutritional supplement

An investigation was recently conducted in Italy on around 200 post-Covid patients suffering from persistent fatigue, who were advised to take Apportal for 28 days

Content provided BY FedEx

Scaling up for Vaccine Delivery in 2021

The convergence of the seasonal flu and COVID-19 transmissions this winter presents an unprecedented challenge not just for the logistics industry but for people around the world. So how are we preparing to ship billions of vaccines across Asia Pacific?

Content provided BY Q² Solutions

Elevating Effective Outcomes with Companion Diagnostics

Companion diagnostics (CDx) is a keystone for pharma to create more precise drug therapies as personalized medicine accelerates. Here’s why a CDx central laboratory partner is necessary.

Content provided BY Federal Equipment Company

Milling for Tablet Making

Preparing ingredients for tablet making is far more critical than most give it credit. The main objective in milling is to reduce particle size to within a specific range while minimizing the generation of fines (dusty particles).

Content provided BY Clinical Ink

Handling complexity in GI trials ⁠— a purpose-built eCOA/ePRO solution

The accelerating complexity of gastroenterology protocols has exceeded the capacity of most electronic clinical outcome assessments (eCOAs) to adapt.

Content provided BY PRA Health Sciences

Challenges Arise as the Need for Pediatric Research Increases

With pediatric clinical trials increasing with the RACE Act, we need to consider the hurdles that will be faced when it comes to enrollment, costs, and trial design.

Content provided BY Merck KGaA, Darmstadt, Germany

Challenges in choosing the correct HPLC/LC-MS column for biologics characterization?

Industry pipelines and portfolios have changed significantly, in recent years, with the small molecules that used to dominate increasingly giving way to biologics.

Content provided BY Clinical Ink

Accelerating Database Lock: Adaptive Design & Remote Monitoring

CASE STUDY: A pharmaceutical company conducting a Phase III study of an investigational ointment required an eSource solution that could support remote monitoring, video uploads, and image capture and provide push-button randomization.

Content provided BY Yourway

Protecting Clinical Trials in Wake of COVID-19

In an unprecedented time of worldwide disruption, Yourway helps you navigate the critical supply chain journey for successful clinical trial development, execution, and conclusion.

Content provided BY Advarra

Managing Research Risks During an Emerging Infectious Diseases Event: A Coronavirus Case Study

The news is filled with stories about the novel 2019 coronavirus (2019-nCov or SARS-CoV-2). Emerging infectious diseases are part of the reality of a globalized civilization